Study Finds Weight Loss via GLP-1 Medications Attracts More Stigma Than Diet and Exercise
Similar Articles
GLP-1 Medications Linked to Reduced Psychiatric Hospitalizations and Sick Leave
Study Links GLP-1 Use in Diabetes and Obesity to Higher Bone-Related Condition Rates
Endoscopic Procedure Shows Promise in Preventing Weight Regain After GLP-1 Medication Use
Semaglutide Shows Significant Weight Loss Benefits for Older Adults with Obesity
New Enzyme Discovery Could Improve GLP-1 Drugs Like Ozempic and Wegovy
A new study reveals that people who lose weight using GLP-1 medications like Ozempic and Wegovy are viewed more negatively than those who lose weight through diet and exercise, or even those who don't lose weight at all. The research, published in the International Journal of Obesity, also found that weight regain is stigmatized regardless of how the initial weight was lost. This stigma is concerning as it is linked to negative health outcomes like increased stress and avoidance of medical care.
Facts First
- Participants rated GLP-1 users more negatively than those who lost weight through diet and exercise.
- GLP-1 users were also rated more negatively than someone who had not lost weight at all.
- Weight regain was viewed negatively compared to weight maintenance, regardless of the initial weight loss method.
- The study examined scenarios where individuals stop GLP-1s due to cost, insurance, or side effects, leading to regain.
- Weight stigma is linked to negative health outcomes including stress and avoiding medical care.
What Happened
A study led by Erin Standen of Rice University found that participants rated the GLP-1 user more negatively than those who lost weight through traditional methods and more negatively than someone who had not lost weight at all. Participants evaluated a fictional individual based on three weight history scenarios: losing weight using a GLP-1 medication, losing weight through diet and exercise, or not losing weight at all.
Why this Matters to You
If you or someone you know is considering or using medications like Ozempic for weight management, this research suggests you may face unfair social judgment. This stigma could affect mental well-being and might discourage people from seeking effective medical treatments. Furthermore, the study highlights that weight regain attracts negative views, which could add pressure during a vulnerable time.
What's Next
The researchers have identified a new form of bias linked to modern weight-loss methods. This finding may lead to further studies on how to reduce medication-related stigma in healthcare and public discourse. It also underscores a need for broader conversations about weight management that recognize the legitimacy of medical interventions alongside lifestyle changes.